Sweden Biotechnology & Medical Research

Modus Therapeutics Holding AB (MODTX)

Track

Track

Ticker: MODTX Exchange: STO
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Viktor, Johan, John Drovta, Dighed, Öhd Chief Executive Officer (CEO)/Managing Directory, Deputy CEO/Deputy Managing Director, Other member of the company's administrative, management or supervisory body
Through Karolinska Development AB, a closely affiliated person
Transaction date
Purchase
Price
458.64
Quantity 4,740
Value SEK4,811,395
John Öhd Chief Executive Officer (CEO)/Managing Directory Officer
Transaction date
Purchase
Price
175.29
Quantity 37,636
Value SEK2,660,718
John Öhd Chief Executive Officer (CEO)/Managing Directory Officer
Transaction date
Sale
Price
448.77
Quantity 28,205
Value SEK4,362,154
John Öhd Chief Executive Officer (CEO)/Managing Directory Officer
Transaction date
Sale
Price
0.90
Quantity 277,686
Value SEK249,917
Claes Lindblad Chief Financial Officer (CFO) Officer
Transaction date
Purchase
Price
4.47
Quantity 3,000
Value SEK13,410
Claes Lindblad Chief Financial Officer (CFO) Officer
Transaction date
Purchase
Price
6.40
Quantity 7,812
Value SEK49,997
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-09-01 2025-09-01 B Purchase
Viktor, Johan, John Drovta, Dighed, Öhd

Chief Executive Officer (CEO)/Managing Directory, Deputy CEO/Deputy Managing Director, Other member of the company's administrative, management or supervisory body

Through Karolinska Development AB, a closely affiliated person
4,740
458.64
SEK4,811,395 		4,740 458.64 SEK4,811,395
2025-08-28 2025-08-27 B Purchase
John Öhd

Chief Executive Officer (CEO)/Managing Directory

Officer
37,636
175.29
SEK2,660,718 		37,636 175.29 SEK2,660,718
2025-08-21 2025-08-20 S Sale
John Öhd

Chief Executive Officer (CEO)/Managing Directory

Officer
28,205
448.77
SEK4,362,154 		28,205 448.77 SEK4,362,154
2025-08-21 2025-08-19 S Sale
John Öhd

Chief Executive Officer (CEO)/Managing Directory

Officer
277,686
0.90
SEK249,917 		277,686 0.90 SEK249,917
2021-12-01 2021-12-01 B Purchase
Claes Lindblad

Chief Financial Officer (CFO)

Officer
3,000
4.47
SEK13,410 		3,000 4.47 SEK13,410
2021-07-21 2021-07-20 B Purchase
Claes Lindblad

Chief Financial Officer (CFO)

Officer
7,812
6.40
SEK49,997 		7,812 6.40 SEK49,997
Explore more

More insider trading research around Modus Therapeutics Holding AB

More insider trades in Sweden
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in Europe